Kansas Wins More Than $700,000 in Paxil Lawsuit Against Glaxo
The state of Kansas is about to receive more than $700,000 from drug maker GlaxoSmithKline as part of a settlement from a lawsuit that also included defendant SB Pharmco Puerto Rico Inc.
Information that was released by the office of the Kansas Attorney General, Derek Schmidt, says the settlement is meant to solve the problem of the allegations that were made against the manufacturing practices that caused some of Glaxo’s drugs to be tainted. The actual settlement of more than $40 million was to be distributed to many different states. In Schmidt’s explanation to this, he says, "Consumers expect medications prescribed by their doctors to be effective and safe. This settlement holds drug manufacturers accountable for providing safe, reliable products."
In the lawsuit, GlaxoSmithKline and SB Pharmco Puerto Rico were accused of using deceptive practices when it came to the making and selling of various different batches of different drugs including Paxil CR. The manufacturing plant that they were talking about in the lawsuit has been closed since 2009. The claims also said that the companies used poor manufacturing techniques when they made the drugs, causing them to become tainted.
A release from the Kansas attorney general's office states that every tainted drug from this incident has been recalled and are all past their expiry dates by now. Regardless, the AG still wants patients who were taking any of the drugs that were mentioned in this incident to talk to their doctors if they think that they were taking any of the tainted drugs.
This case is not the first time that Glaxo has gone under the gun for problems associated with Paxil. They have been dealing with lawsuits against the drug’s side effects for years. Most recently, Paxil birth defects have been making the news. The hits just keep on coming over Paxil, yet Glaxo continues to claim that these drugs are safe.
